rs1554604771
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP2PP3BP6
The NM_017780.4(CHD7):c.6989_6990delinsCT(p.Gly2330Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar. Synonymous variant affecting the same amino acid position (i.e. G2330G) has been classified as Benign.
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHD7 | NM_017780.4 | c.6989_6990delinsCT | p.Gly2330Ala | missense_variant | 33/38 | ENST00000423902.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.6989_6990delinsCT | p.Gly2330Ala | missense_variant | 33/38 | 5 | NM_017780.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2018 | The c.6989_6990delGCinsCT variant (also known as p.G2330A), located in coding exon 32 of the CHD7 gene, results from an in-frame deletion of GC and insertion of CT at nucleotide positions 6989 to 6990. This results in the substitution of the glycine residue for an alanine residue at codon 2330, an amino acid with similar properties. In one study, c.6989G>C (p.G2330A) was reported as a rare missense variation of unknown pathogenicity identified in a cohort of samples submitted for CHD7 analysis (Bartels CF et al. Genet Test Mol Biomarkers, 2010 Dec;14:881-91). In another study, c.6989G>C (p.G2330A) was classified as a benign CHD7 missense variant present in two or more controls and/or found in the homozygous state; however, more specific information was not provided (Bergman JE et al. Hum. Mutat., 2012 Aug;33:1251-60). This amino acid position is highly conserved in available vertebrate species. Based on available evidence to date, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 27, 2018 | The c.6989_6990delinsCT variant in CHD7 is classified as benign because it had b een identified in 0.26% (61/23434) of African chromosomes including 1 homozygote by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; d bSNP rs77704609 and rs559382275). ACMG/AMP Criteria applied: BA1. - |
CHARGE syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at